Friday, March 24, 2006


Hepatitis C Awareness - Hepatitis C


Hepatitis C
Evolving Treatments for Chronic Viral Hepatitis C From Howard J. Worman, M. D. Hepatitis Foundation International Information about an organization established to reduce suffering caused by hepatitis.

Hepatitis C: Current Treatment
side effects and effective in only about half of patients, more research is definitely needed to develop safer, more effective and cheaper drugs (see Evolving Treatments for Chronic Viral Hepatitis C

Management of Hepatitis C (CBM 97-1)
archived January 1989 through January 1997 2200 Citations Prepared by Ronald L. Gordner, M.L.S., National

Hepatitis C: The Forum: The Issues: Ann Jesse's Testimony
Are you aware that viral hepatitis C is an equal opportunity infector that has the potential of wreaking havoc on people of all ages, genders, races and sexual orientation?

Tuesday, March 21, 2006


Hepatitis C Awareness - Editorial: Is auto insurance age discrimination?


Editorial: Is auto insurance age discrimination?
When it comes to auto insurance rates, who you are determines what you pay. Automobile insurance premiums are based on a large number of factors, some of which you can control, and some of which, alas, are incontrovertible facts of life. Statistically, a sixteen-year old boy with a 300 horsepower sports car in a big city is far more likely to hit something than a 35 year-old married guy driving a minivan around the suburbs but to charge an entire age bracket more sounds an awful lot like age discrimination to me. While you cant change your age and some other factors, there are things that you can do to keep insurance premiums as low as possible.

VX-950 To Get Fast Tracked
As you may recall we've been saying VX-950 is the revolutionary new therapy to watch for HCV. Now it looks like the FDA agrees this treatment is quite promising and deserving of faster approval than a lesser worthy approach. Another...

Viral Hepatitis
Title: Viral HepatitisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/5/2005

Indenix is Nearing Phase III for Valopicitabine
It is always good to see progress with alternatives to current medical therapy for HCV. Even though companies that are working on solutions to be used with interferon are not really offering anything groundbreaking or revolutionary, it does continue the...